尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Smith Cynthia, 董事. Director active across 5 companies, notably Akebia Therapeutics, Inc.. Cumulatively, 18 disclosures have been published. Activity tracked since 2 June 2021. The latest transaction was filed on 11 August 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 条申报中的 18 条
Smith Cynthia is an Administrateur associated with Akebia Therapeutics, Inc., AGIOS PHARMACEUTICALS, INC., Spero Therapeutics, Inc., Dicerna Pharmaceuticals Inc and Agios Pharmaceuticals, INC. The record covers 18 filings in total, all within the recent sample, with transactions described as Attribution, and the date range runs from 2021-06-03 to 2026-06-23. The buy and sell amounts shown for this sample are 0 and 0 eur, and one filing dated 2021-12-29 at Dicerna Pharmaceuticals Inc shows 112521.5233965187 eur.